East Providence, RI1 Active Studies

Advanced Solid Tumors Clinical Trials in East Providence, RI

Find 1 actively recruiting advanced solid tumors clinical trials in East Providence, RI. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
39
Enrolling

Recruiting Advanced Solid Tumors Studies in East Providence

About Advanced Solid Tumors Clinical Trials in East Providence

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 1 advanced solid tumors clinical trials recruiting participants in East Providence, RI. These studies are seeking a combined 39 participants. Research is being sponsored by BioNTech SE. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in East Providence — FAQ

Are there advanced solid tumors clinical trials in East Providence?

Yes, there are 1 advanced solid tumors clinical trials currently recruiting in East Providence, RI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in East Providence?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the East Providence research site will contact you about next steps.

Are clinical trials in East Providence free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many East Providence studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 1 active trials in East Providence are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated July 13, 2026 from ClinicalTrials.gov